CPEG
GCEP

Now that CPEG is built, buildcpeg.blogspot.com will now become dormant, but visible. A new blog has been reserved for future communications to and within the CPEG-GCEP community:

cpeg-gcep.blogspot.com

Pleasebookmark your favourites list accordingly. Links back to this blog, and to selected recent archive months, shall be placed in the new blog.

Thank you for participating in the (re-?)birth of this organization.

As part of its centennial program, Hôpital Ste-Justine in Montreal will host this symposium on January 31, 2007. For further details please click here.

Pediatric Endocrinologist
The University of British Columbia (UBC) and BC Children’s Hospital (BCCH)
Vancouver, British Columbia

The UBC Department of Pediatrics and BCCH are seeking a full-time Pediatric Endocrinologist.

BC Children's Hospital (BCCH) is the only dedicated pediatric tertiary care centre for the province of British Columbia in Canada serving a population of approximately 4 million people. The Department of Pediatrics within the University British Columbia (UBC) resides within BCCH. UBC is the second-largest University in Canada with an undergraduate population of 30,000 students. The medical school admits over 200 undergraduates per year but is in the process of rapid expansion. The Endocrinology and Diabetes Unit at BCCH includes 5 physicians and a team of dedicated clinical nurse specialists, dietitians and a social worker. The philosophy of the Unit is to maintain its status of clinical excellence through ongoing clinical and basic science research, and the education of future health care providers. The research focus is on childhood and adolescent obesity and diabetes.

The successful applicant will require specialist qualifications with specific pediatric endocrinology clinical training. Additional training in Public Health, Epidemiology or Hospital Administration is an asset. The proposed position will have a clinical component that includes both endocrinology and diabetes in and out patient clinic as well as an administrative component that includes organization of the regional clinics in endocrinology and diabetes throughout British Columbia in collaboration with British Columbia’s Children’s Hospital and the University of British Columbia. Salary and UBC rank will be commensurate with qualifications and experience.

The anticipated start date for the position is July, 2007.

Interested Individuals should submit their most current Curriculum Vitae; covering letter and 3 letters of reference, by January 31, 2007 to:

Dr. Jean-Pierre Chanoine,
Clinical Professor and Head
Division of Endocrinology
Room K4-213, BC Children’s Hospital
4480 Oak Street, Vancouver, BC Canada
V6H 3V4
jchanoine[no-spam "AT"]cw.bc.ca

Our blog's URL address will soon be distributed to the pediatric endo nurses across the country. So welcome, dear colleagues, to a new and improved CPEG, designed to be an inclusive community of all health professionals and scientists with an interest in pediatric endocrinology. Including our esteemed nursing colleagues! At the last CDA/CSEM meeting in Toronto, we have established an official structure, including by-laws. Please scroll down below to have a look at what we have come up with.
Canadian pediatric endocrine nurses are currently exploring a more structured organization. At CPEG we are hoping to resume our joint physician - nurse meetings that, in the past, were held in conjunction with a clinical trial group meeting held by a single pharmaceutical sponsor. We regret that this will not happen at the inaugural independent meeting in London in April 2007, since the available dates ended up being too close to the PENS meeting, and we were told that a full nursing program in London would not succeed in drawing a large participation; travel and work schedules would simply not permit attendance at both. But let's make up for it in 2008!
We hope that what we are building will appeal to our Canadian nursing colleagues from coast to coast to coast.

Dear Colleagues
The Section of Pediatric Endocrinology and Metabolism at the Winnipeg Children’s Hospital is currently looking for a fourth pediatric endocrinologist to join our team. We also have a locum position available starting in the New Year.
The Winnipeg Children’s Hospital services the urban, rural and remote areas of Manitoba and northwestern Ontario. We see a wide variety of endocrine problems, type 1 diabetes and a large population of youth with type 2 diabetes. The section is actively involved in clinical research. Please direct inquiries to me. I look forward to discussion with anyone who would be interested in further details.

Sincerely

Elizabeth Sellers
Head, Section of Endocrinology and Metabolism
Department of Pediatrics and Child Health
University of Manitoba
Tel: 204-787-4351
Fax: 204-787-1655
Email: esellers [no spam "at"] exchange.hsc.mb.ca

Colleagues, please take note of the following invitation:

To The Secretaries of Pediatric Endocrine Societies
Please include the following announcement in your Newsletter of your society. Having obtained interesting preliminary results in our worldwide survey on the revalence of malignancy in patients with congenital IGF-I deficiency, we are enlarging the scope of our study by including patients with GHRH-R defects, IGHD, IGF-I-R defects and also patients with PROP-1, Pit-1, HesX-1 mutation (and certainly new patients with LS)
Should you know and/or follow patients with the above diagnoses please contact us to the following addresses and we shall send you further details and a simple questionnaire. Looking forward for your collaboration,
Sincerely,
Zvi Laron,MD
Endocrinology and Diabetes Research Unit
Schneider Childrens' Medical Center
14 Kaplan st.
Petah-Tikva 49202
Israel
Tel: 972-2-9253610-1
Fax: 972-3-9222996
email: laronz [nospam "AT"] clalit.org.il
or to:
Orit Shevah, res.ass.
shev72 [nospam "AT"] bezeqit.net

Note that I have altered the email addresses so that it cannot be easily lifted by Internet bottom-feeders trawling for addresses. Please make manual adjustments to the address if you will be contacting Dr. Laron.

The Constitutional Conference has spoken. Immediately below you will find the Statement of Purpose as well as all Articles in our newly established By-Laws, as amended and approved in Toronto last week. The text below is my best effort to reflect the will of the Group, based on my notes during the session chaired by Dr. Guy Van Vliet. Please review the final version here, and offer any challenges to the text if you feel I have not properly documented the will of the Group. I will then triple-check my notes and correct if necessary.
Thank you for your proofreading.

WHEREAS the Canadian Pediatric Endocrine Group (CPEG, or the Group) was formed in 1996 as a section of the Canadian Society for Endocrinology and Metabolism (CSEM) in order to:
(i) foster excellent collaboration in research and education among its members;
and
(ii) Promote excellence in clinical care of and advocacy for the patients served by its members;
WHEREAS CPEG has met twice yearly in conjunction with the CSEM Annual Meeting and a sponsored meeting of investigators of a clinical trial of growth hormone;
WHEREAS CPEG members desire complete autonomy over the organization of the group’s scientific meetings;
We, the members of CPEG, hereby adopt the following By-Laws.

The CPEG secretariat shall be in Canada, in the professional office of the Secretary.

3.1 Active: individual health professionals and scientists actively involved in pediatric endocrine care, research and/or education. Any qualified health professional or scientist practicing in the field of pediatric endocrinology and metabolism is eligible. Applicants shall be deemed qualified upon the support of any two (2) Active Members in good standing.
3.2 Founding: those Active Members who contributed financially to the establishment of the group in 2006, as described in Article 4;
3.3 Emeritus: individuals who have been Active Members for at least five (5) membership years or who had been members of CPEG prior to 2006, and who have retired from active practice (clinical/research/educational);
3.4 Associate: fellows, residents, graduate students in the field of pediatric endocrinology and metabolism. Applicants shall be admitted upon the support of one Active Member in good standing if this Member is the trainee’s supervisor, or of any two (2) Active Members in good standing.

A single contribution of five hundred Canadian dollars ($500) is required of Founding Members in the calendar year 2006.
Membership dues shall be assessed annually. The amount of the membership fee shall remain in effect until modified by approval at an Annual or Special General Meeting. The failure to contribute membership dues for two (2) consecutive years shall lead to automatic resignation from membership, and will require re-application for membership to resume. Only Active Members in good standing enjoy the privileges of Active Membership, including voting and the holding of an Executive office.

5.1 CPEG shall hold the following Meetings:
5.1.1 Annual General Meeting of CPEG members shall be held on such date, at such time and location as the Executive may determine from time to time. There shall be at least one Annual General Meeting per calendar year.
5.1.2 Special General Meeting may be called at any time by the President, by the Past-President, by the President-Elect, by a resolution of the Executive, or by signed written request to the Secretary of not less than one-fifth (1/5) of Active Members in good standing.
5.1.3 Scientific Meeting of CPEG shall take place at least once a year. The program committee shall be responsible for scientific content and a local organizing committee shall be named at least one year in advance.
5.1.4 Executive Meeting shall be held on such date, at such time and location as the Executive may determine from time to time. There shall be at least one Executive Meeting per calendar year.
5.2 Notice of Meeting shall be by electronic mail to each member’s address on file in the secretarial office. Notice shall be sent not less than sixty (60) days prior to the Meeting, except for Special Meetings for which notice shall be sent not less than fourteen (14) days and not more than sixty (60) days in advance.
5.3 Voting privileges at a General Meeting are retained by Active Members in good standing. A quorum at a General Meeting is established by the presence of one fourth (1/4) of such members. Resolutions are approved by simple majority vote of members present and voting. Voting shall be by secret ballot only for contested elections to the Executive or upon approved resolution. The President shall only vote on a resolution or amendment in the event of a tie or of a secret ballot.

6.1 The Executive consists of the following volunteer positions, to be filled by Active Members in good standing:
6.1.1 President shall: exercise supervision over the affairs of CPEG and of its Executive; chair the General and Executive Meetings; participate ex officio on all Standing Committees; have joint authority with the Treasurer to make payments on behalf of the Group; shall represent the Group in relations with other scientific organizations; have other duties as the Executive may determine, from time to time, by resolution. The non-renewable term of office shall be two years.
6.1.2 President-Elect shall: assume the duties of President in the absence or incapacity or failure to act of the President; have other duties as the Executive may determine, from time to time, by resolution; assume the office of the President at the end of the President’s term of office. The non-renewable term of office shall be two years or until a successor is elected.
6.1.3 Past President shall: participate ex officio on the Executive; resume the duties of the President in the absence or incapacity or failure to act of both the President and President-Elect; have other duties as the Executive may determine, from time to time, by resolution. A President must complete a full mandate to become Past President. The non-renewable term of office shall be a maximum of two years.
6.1.4 Secretary shall: issue Notices of General and Executive Meetings; record the minutes of General and Executive Meetings; act as scrutineer for all votes at General and Executive Meetings; take charge of the keeping and filing of all reports, minutes, correspondence and other documents pertaining to the business of the Group. The renewable term of office shall be two years or until a successor is elected. This position may be combined with that of Treasurer.
6.1.5 Treasurer shall: have general charge of the finances of the Group; have joint authority with the President to make payments on behalf of the Group; submit to the Executive an accounting of the finances of the Group after the close of each financial year and as requested from time to time by the Executive. The renewable term of office shall be two years or until a successor is elected. This position may be combined with that of Secretary.
6.1.6 Standing Committee Chair shall: act as member-at-large on the Executive; have other duties as the Executive may determine, from time to time, by resolution. The renewable term of office shall be two years or until a successor is elected.
6.2 Vacancy: Unless specified elsewhere in these By-Laws, the Executive shall name a replacement for any vacancy created prior to and until the next General Meeting.

7.1 Fellowship Committee: shall oversee postgraduate scholarships, including fundraising, the selection of candidates, and any other business as deemed necessary for the proper administration of this program. The Chair of the Fellowship Committee may not be a program director of a pediatric endocrinology training program accredited by the Royal College of Physicians and Surgeons of Canada.
7.2 Scientific Program Committee: shall organize the scientific content of the Annual Scientific Meeting.

The Executive shall, from time to time, name, by resolution, ad hoc committees with specific terms of reference.

9.1 Fiscal Year shall coincide with Membership Year, and shall begin on the first day of January and end on the 31st day of December in any given calendar year.
9.2 Accounts. The accounts of the Group shall be kept with a financial institution carrying a legal business within Canada, and approved by resolution at a General Meeting. The President and Treasurer (or designates, as may from time to time be necessary) shall retain joint signing authority for any disbursements.
9.3 Audit. The Treasurer shall, at least once yearly, submit an accounting of the finances of the Group to not less than two (2) Active Members, who do not sit on the Executive, for review. A full external audit shall be undertaken upon resolution at an Executive or General Meeting.

The rules contained in the current edition of Robert’s Rules of Order Newly Revised shall govern in all cases to which they are applicable unless they are inconsistent with these By-Laws or any special rules of order CPEG may adopt.

11.1 These By-Laws may be amended at any General Meeting by a two-thirds majority of members present and voting plus members voting by proxy, provided that a written Notice of Proposed Amendment is provided to Active Members at or before the provision to Active Members of the Notice of General Meeting.
11.2 Amendments may be made to the proposed By-Law Amendment by simple majority vote of Active Members present and voting, except that no Amendment to a proposed By-Law amendment may increase the modification of the Article to be amended.

Harvey Guyda has forwarded me a job posting (in the USA) that might be of interest to some members of CPEG:

PEDIATRIC ENDOCRINOLOGY AT THE UNIVERSITY OF CHICAGO

The Department of Pediatrics at the University of Chicago is recruiting a physician-scientist to lead the Section of Endocrinology and/or to direct a program within the new Institute for Molecular Pediatric Science (IMPS), to be housed in a newly constructed multi-disciplinary research institute with world class facilities. Candidates must have an outstanding record of achievement in a research field related to pediatric endocrinology. The successful applicant will be a leader in the field, with a strong commitment to research, clinical excellence, teaching of medical students and residents, mentoring of junior faculty, and collaboration.

The University of Chicago offers numerous opportunities to collaborate with leading biomedical researchers in a variety of settings, including IMPS, an active General Clinical Research Center, the Committee on Molecular Nutrition and Metabolism, and the Howard Hughes Medical Institute. The clinical environment in the Section of Endocrinology is superb, comprising a large clinical practice, with state-of-the art facilities including the new Comer Children’s Hospital (opened February 2005), and La Rabida Children’s Hospital, which is devoted to the comprehensive care of children with chronic diseases, including diabetes. The Section also maintains an NIH-funded pediatric endocrinology training grant. Additional opportunities exist for leadership within the pediatric arm of the University’s General Clinical Research Center.

Please send a CV and a personal statement of your research accomplishments and future interest to the Search Committee Chair:
Rebecca B. Lipton, PhD
The University of Chicago
Associate Professor of Pediatrics
5841 S. Maryland Ave.
MC1027
Chicago, IL 60637
lipton@uchicago.edu
The University of Chicago is an Affirmative Action/Equal Opportunity Employer